Dimethyl sulfoxide delays PrPsc accumulation and disease symptoms in prion-infected hamsters

Brain Research

Volumn 983, Issue 1-2, 2003, Pages 137-143

  Shaked, Gideon M ^a   Engelstein, Roni ^a   Avraham, Inbal ^a   Kahana, Esther ^b   Gabizon, Ruth ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Bovine spongiform encephalopathy; Creutzfeldt Jakob disease; Dimethyl sulfoxide; Hamster; Prion; PrPsc accumulation; Scrapie

Indexed keywords

DIMETHYL SULFOXIDE;

ANIMAL MODEL; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; IN VITRO STUDY; MEDICAL ASSESSMENT; NERVE DEGENERATION; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN FOLDING; REDUCTION; SYRIAN HAMSTER;

EID: 0042160180     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(03)03045-2     Document Type: Article

References (41)

1. Martindale, the extra Pharmacopoeia. 31 Edition:1996;Royal Pharmaceutical Society, London.
2. Adjou K.T., Privat N., Demart S., Deslys J.P., Seman M., Hauw J.J., Dormont D. MS-8209, an amphotericin B analogue, delays the appearance of spongiosis, astrogliosis and PrPres accumulation in the brain of scrapie-infected hamsters. J. Comp. Pathol. 122:2000;3-8.
3. Beringue V., Adjou K.T., Lamoury F., Maignien T., Deslys J.P., Race R., Dormont D. Opposite effects of dextran sulfate 500, the polyene antibiotic MS-8209, and Congo red on accumulation of the protease-resistant isoform of PrP in the spleens of mice inoculated intraperitoneally with the scrapie agent. J. Virol. 74:2000;5432-5440.
4. Brown P. Drug therapy in human and experimental transmissible spongiform encephalopathy. Neurology. 58:2002;1720-1725.
5. Butler D.A., Scott M.R., Bockman J.M., Borchelt D.R., Taraboulos A., Hsiao K.K., Kingsbury D.T., Prusiner S.B. Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J. Virol. 62:(5):1988;1558-1564. LHM: This journal is received by the Medical Library, Ein Kerem LHC: 1967-SHELF 45.
6. Caspi S., Halimi M., Yanai A., Sasson S.B., Taraboulos A., Gabizon R. The anti-prion activity of Congo red. Putative mechanism. J. Biol. Chem. 273:1998;3484-3489.
7. Caughey B., Baron G.S. Factors affecting interactions between prion protein isoforms. Biochem. Soc. Trans. 30:2002;565-569.
8. Caughey B., Ernst D., Race R.E. Congo red inhibition of scrapie agent replication. J. Virol. 67:(10):1993;6270-7272. LHM: This journal is received by the Medical Library, Ein Kerem LHC: 1967-SHELF 45.
9. Caughey B., Race R.E. Potent inhibition of scrapie-associated PrP accumulation by congo red. J. Neurochem. 59:(2):1992;768-771. LHM: This journal is received by the Medical Library, Ein Kerem LHC: 1956-SHELF 42.
10. Caughey B., Raymond G.J. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J. Virol. 67:1993;643-650.
11. Czub M., Braig H.R., Diringer H. Pathogenesis of scrapie: study of the temporal development of clinical symptoms, of infectivity titres and scrapie-associated fibrils in brains of hamsters infected intraperitoneally. J. Gen. Virol. 67:(Pt 9):1986;2005-2009. LHM: This journal is received by the Medical Library, Ein Kerem LHC: 1967-SHELF 45.
12. Czub M., Braig H.R., Diringer H. Replication of the scrapie agent in hamsters infected intracerebrally confirms the pathogenesis of an amyloid-inducing virosis. J. Gen. Virol. 69:(Pt. 7):1988;1753-1756. LHM: This journal is received by the Medical Library, Ein Kerem LHC: 1967-SHELF 45.
13. Gabizon R., Meiner Z., Halimi M., Ben Sasson S.A. Heparin-like molecules bind differentially to prion-proteins and change their intracellular metabolic fate. J. Cell Physiol. 157:(2):1993;319-325. LHM: This journal is received by the Medical Library, Ein Kerem LHC: 1975-SHELF 44.
14. Giese A., Kretzschmar H.A. Prion-induced neuronal damage - the mechanisms of neuronal destruction in the subacute spongiform encephalopathies. Curr. Top. Microbiol. Immunol. 253:2001;203-217.
15. Glenner G.G. Amyloid deposits and amyloidosis. The beta-fibrillosis. New Engl. J. Med. 302:1980;1333-1343.
16. Hanai N., Ishihara T., Uchino F., Imada N., Fujihara S., Ikegami J. Effects of dimethyl sulfoxide and colchicine on the resorption of experimental amyloid. Virchow's Arch. A Pathol. Anat. Histol. 384:1979;45-52.
17. Head M.W., Ironside J.W. Inhibition of prion-protein conversion: a therapeutic tool? Trends Microbiol. 8:2000;6-8.
18. Heppner F.L., Musahl C., Arrighi I., Klein M.A., Rulicke T., Oesch B., Zinkernagel R.M., Kalinke U., Aguzzi A. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science. 294:2001;178-182.
19. Kito S., Itoga E., Inokawa M., Hironaka M., Kishida T., Shinoda T. Studies on biological actions of dimethyl sulfoxide in familial amyloidosis. Ann. NY Acad. Sci. 411:1983;52-66.
20. Korth C., May B.C., Cohen F.E., Prusiner S.B. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc. Natl. Acad. Sci. USA. 98:2001;9836-9841.
21. Murav'ev I.O. Evaluation of the effect of dimethyl sulfoxide on experimental amyloidosis. Revmatologiia. 1:1990;44-46.
22. O'Dwyer P.J., McCabe D.P., Sickle-Santanello B.J., Woltering E.A., Clausen K., Martin E.W. Jr. Use of polar solvents in chemoprevention of 1,2-dimethylhydrazine-induced colon cancer. Cancer. 62:1988;944-948.
23. Oesch B., Westaway D., Walchli M., McKinley M.P., Kent S.B., Aebersold R., Barry R.A., Tempst P., Teplow D.B., Hood L.E., et al. A cellular gene encodes scrapie PrP 27-30 protein. Cell. 40:(4):1985;735-746. LHM: This journal is received by the Medical Library, Ein Kerem LHC: 1974-SHELF 39.
24. Otto M., Cepek L., Ratzka P., Doehlinger S., Wiltfang J., Irle E., Pergande G., Ellers-Lenz B., Windl O., Kretzschmar H., Poser S., Prange H. Efficacy of flupirtine on cognitive function in patients with Creutzfeldt-Jakob disease. Neurobiol. Aging. 23:2002;497.
25. Pan K.M., Baldwin M., Nguyen J., Gasset M., Serban A., Groth D., Mehlhorn I., Huang Z., Fletterick R.J., Cohen F.E., et al. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA. 90:(23):1993;10962-10966. LHM: This journal is received by the Medical Library, Ein Kerem LHC: 1947-shelf 0.
26. Peretz D., Williamson R.A., Kaneko K., Vergara J., Leclerc E., Schmitt-Ulms G., Mehlhorn I.R., Legname G., Wormald M.R., Rudd P.M., Dwek R.A., Burton D.R., Prusiner S.B. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature. 412:2001;739-743.
27. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. USA. 95:1998;13363-13383.
28. Prusiner S.B. Shattuck lecture - neurodegenerative diseases and prions. New Engl. J. Med. 344:2001;1516-1526.
29. Prusiner S.B., Cochran S.P., Downey D.E., Groth D.F. Determination of scrapie agent titer from incubation period measurements in hamsters. Adv. Exp. Med. Biol. 134:1981;385-399. LHM: This journal is received by the Medical Library, Ein Kerem LHC: 1967-.
30. Ravid M., Kedar I., Sohar E. Effect of a single dose of dimethylsulfoxide on renal amyloidosis. Lancet. 1:1977;730-731.
31. Ravid M.S.J., Lang R. Prolonged DMSO treatment in 13 patients with systemic amyloidosis. Ann. Rheum. Dis. 41:1982;587-592.
32. Regelson W., Harkins S.W. Amyloid is not a tombstone; a summation. The primary role for cerebrovascular and CSF dynamics as factors in Alzheimer's disease (AD): DMSO, fluorocarbon oxygen carriers, thyroid hormonal, and other suggested therapeutic measures. Ann. NY Acad. Sci. 826:1997;348-374.
33. Rudyk H., Vasiljevic S., Hennion R.M., Birkett C.R., Hope J., Gilbert I.H. Screening Congo Red and its analogues for their ability to prevent the formation of PrP-res in scrapie-infected cells. J. Gen. Virol. 81:2000;1155-1164.
34. Shaked G.M., Fridlander G., Meiner Z., Taraboulos A., Gabizon R. Protease-resistant and detergent-insoluble prion protein is not necessarily associated with prion infectivity. J. Biol. Chem. 274:1999;17981-17986.
35. Shaked G.M., Meiner Z., Avraham I., Taraboulos A., Gabizon R. Reconstitution of prion infectivity from solubilized protease-resistant PrP and non-protein components of prion rods. J. Biol. Chem. 276:2001;14324-14328.
36. Shaked G.M., Shaked Y., Kariv-Inbal Z., Halimi M., Avraham I., Gabizon R. A protease-resistant prion protein isoform is present in urine of animals and humans affected with prion diseases. J. Biol. Chem. 276:2001;31479-31482.
37. Shen C.L., Murphy R.M. Solvent effects on self assembly of beta amyloid peptide. Biophys. J. 69:1995;640-651.
38. Supattapone S., Nguyen H.O., Cohen F.E., Prusiner S.B., Scott M.R. Elimination of prions by branched polyamines and implications for therapeutics [In Process Citation]. Proc. Natl. Acad. Sci. USA. 96:1999;14529-14534.
39. Taraboulos A., Jendroska K., Serban D., Yang S.L., DeArmond S.J., Prusiner S.B. Regional mapping of prion proteins in brain. Proc. Natl. Acad. Sci. USA. 89:1992;7620-7624.
40. Tatzelt J., Prusiner S.B., Welch W.J. Chemical chaperones interfere with the formation of scrapie prion protein. EMBO J. 15:1996;6363-6373.
41. Taylor D.M. Current perspectives on bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. Clin. Microbiol. Infect. 8:2002;332-339.